ISPOR - POSB200 Type of Polypharmacy and the Risk of Mortality Among Patients with Chronic Heart Failure Newly Diagnosed? A Nested Case-Control Study

POSB200 Type of Polypharmacy and the Risk of Mortality Among Patients with Chronic Heart Failure Newly Diagnosed? A Nested Case-Control Study

Abstract

Authors

S Perreault M Schnitzer E Disso J Qazi M Dorais

Full Text Cite This Article

Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now